News

Cook Medical said that PMA submission is a critical step in the product development process, giving the FDA the appropriate information to evaluate the safety and efficacy of

With a motto to serve upstream applications from process development laboratory to the full-scale cGMP production suite, their joint attempt is expected to build on the capabilities of

The proposed indication for this combination vaccine is immunization of infants and toddlers against meningococcal serogroups C & Y, and Haemophilus influenzae type b (Hib) diseases at two,

The positive opinion for 2B3-101 by the COMP has specifically been granted for the treatment of glioma. As a proprietary brain-targeted version of the marketed product Caelyx/Doxil (PEG-liposomal

Creative Testing Solutions is a collaboration between Blood Systems and Florida Blood Services that offers blood and tissue facilities access to a national network of high volume donor

The exclusive world-wide development and licence agreement is based on the PolyXen PSA-Factor VIII project being developed with Baxter, a treatment of haemophilia, for improved longer-acting forms of

The findings were presented at the 15th Congress of the European Hematology Association (EHA), June 10-13, in Barcelona, Spain. According to the S*BIO 20 patients were treated at

The Phase III clinical trial is evaluating the patients under 18 to 75 years of age with refractory partial-onset seizures with or without secondary generalised seizures. Topiramate is

Nexavar (sorafenib) tablets was evaluated in patients with advanced non-squamous non-small cell lung cancer (NSCLC). NExUS evaluated Nexavar versus placebo in combination with two chemotherapeutic agents, gemcitabine and